Detalhe da pesquisa
1.
Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal.
Proc Natl Acad Sci U S A
; 112(50): 15444-9, 2015 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26621726
2.
End-to-end approach for the characterization and control of product-related impurities in T cell bispecific antibody preparations.
Int J Pharm X
; 5: 100157, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36687375
3.
Ficolins: novel pattern recognition molecules of the innate immune response.
Immunobiology
; 213(3-4): 297-306, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18406375
4.
A drug development perspective on targeting tumor-associated myeloid cells.
FEBS J
; 285(4): 763-776, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28941174
5.
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity.
J Exp Med
; 215(3): 859-876, 2018 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29436396
6.
Localization of the mouse defense lectin ficolin B in lysosomes of activated macrophages.
J Endotoxin Res
; 12(2): 120-6, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16690015
7.
Targeting Tumor Cells with Anti-CD44 Antibody Triggers Macrophage-Mediated Immune Modulatory Effects in a Cancer Xenograft Model.
PLoS One
; 11(7): e0159716, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27463372
8.
Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia.
Oncotarget
; 7(22): 32532-42, 2016 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-27081038
9.
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.
Cancer Cell
; 30(3): 377-390, 2016 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27622331
10.
RG7386, a Novel Tetravalent FAP-DR5 Antibody, Effectively Triggers FAP-Dependent, Avidity-Driven DR5 Hyperclustering and Tumor Cell Apoptosis.
Mol Cancer Ther
; 15(5): 946-57, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27037412
11.
CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients.
Clin Cancer Res
; 21(12): 2753-62, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25762343
12.
Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.
Cancer Cell
; 25(6): 846-59, 2014 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24898549
13.
Immature mouse granulocytic myeloid cells are characterized by production of ficolin-B.
Mol Immunol
; 56(4): 488-96, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23911405
14.
Functional analysis of mouse ficolin-B and detection in neutrophils.
Immunobiology
; 217(10): 982-5, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22459270
15.
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.
Cancer Cell
; 30(4): 651, 2016 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27728809